704 related articles for article (PubMed ID: 30371540)
21. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
[TBL] [Abstract][Full Text] [Related]
22. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.
Wang F; Zhang W; Guo L; Bao W; Jin N; Liu R; Liu P; Wang Y; Guo Q; Chen B
Cancer Sci; 2014 Aug; 105(8):1063-70. PubMed ID: 24890366
[TBL] [Abstract][Full Text] [Related]
23. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
[TBL] [Abstract][Full Text] [Related]
24. Regulation of hypoxia-inducible factor-1α, regulated in development and DNA damage response-1 and mammalian target of rapamycin in human placental BeWo cells under hypoxia.
Zhou F; Guan LB; Yu P; Wang XD; Hu YY
Placenta; 2016 Sep; 45():24-31. PubMed ID: 27577706
[TBL] [Abstract][Full Text] [Related]
25. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition.
Jampasri S; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080483
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression.
Zhang J; Xu J; Dong Y; Huang B
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29899167
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory stimulation and hypoxia cooperatively activate HIF-1{alpha} in bronchial epithelial cells: involvement of PI3K and NF-{kappa}B.
Jiang H; Zhu YS; Xu H; Sun Y; Li QF
Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L660-9. PubMed ID: 20139176
[TBL] [Abstract][Full Text] [Related]
28. HIF-1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell-like diffuse large B-cell lymphoma cells.
Jin Z; Xiang R; Dai J; Wang Y; Xu Z
Mol Carcinog; 2023 May; 62(5):676-684. PubMed ID: 36789975
[TBL] [Abstract][Full Text] [Related]
29. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
31. Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.
Yeh YH; Wang SW; Yeh YC; Hsiao HF; Li TK
Oncol Rep; 2016 May; 35(5):2887-95. PubMed ID: 26986649
[TBL] [Abstract][Full Text] [Related]
32. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
33. Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway.
Filippi I; Morena E; Aldinucci C; Carraro F; Sozzani S; Naldini A
J Cell Physiol; 2014 Dec; 229(12):2067-76. PubMed ID: 24818793
[TBL] [Abstract][Full Text] [Related]
34. Hydroxysafflor Yellow A Promotes HaCaT Cell Proliferation and Migration by Regulating HBEGF/EGFR and PI3K/AKT Pathways and Circ_0084443.
Zhang Y; Xiao YW; Ma JX; Wang AX
Chin J Integr Med; 2024 Mar; 30(3):213-221. PubMed ID: 37688744
[TBL] [Abstract][Full Text] [Related]
35. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma.
Jiao M; Nan KJ
Int J Oncol; 2012 Feb; 40(2):461-8. PubMed ID: 21922131
[TBL] [Abstract][Full Text] [Related]
36. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
37. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1 alpha/VEGF pathway.
Choi YH; Jin GY; Li LC; Yan GH
PLoS One; 2013; 8(11):e81773. PubMed ID: 24312355
[TBL] [Abstract][Full Text] [Related]
39. Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1/ErbB-PI3K/Akt/mTOR pathway.
Wang J; Zhou J; Wang Y; Yang C; Fu M; Zhang J; Han X; Li Z; Hu K; Ge J
J Cell Mol Med; 2017 Sep; 21(9):1905-1914. PubMed ID: 28271613
[TBL] [Abstract][Full Text] [Related]
40. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.
Nan Y; Guo H; Guo L; Wang L; Ren B; Yu K; Huang Q; Zhong Y
Hum Gene Ther Clin Dev; 2018 Sep; 29(3):156-166. PubMed ID: 30180756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
